EyePoint Pharmaceuticals
EYPT
#5228
Rank
โ‚น132.90 B
Marketcap
โ‚น1,605
Share price
0.45%
Change (1 day)
114.26%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น22.67 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are โ‚น22.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น35.89 B21.41%
2023-12-31โ‚น29.56 B98.12%
2022-12-31โ‚น14.92 B-23.87%
2021-12-31โ‚น19.60 B192.25%
2020-12-31โ‚น6.70 B28.9%
2019-12-31โ‚น5.20 B
2018-06-30โ‚น4.90 B306.45%
2017-06-30โ‚น1.20 B-43.45%
2016-06-30โ‚น2.13 B3.7%
2015-06-30โ‚น2.05 B51.39%
2014-06-30โ‚น1.35 B40.56%
2013-06-30โ‚น0.96 B-15.4%
2012-06-30โ‚น1.14 B-45.58%
2011-06-30โ‚น2.10 B5.24%
2010-06-30โ‚น1.99 B12.43%
2009-06-30โ‚น1.77 B-25.84%
2008-06-30โ‚น2.39 B-42.37%
2007-06-30โ‚น4.15 B-48.72%
2006-06-30โ‚น8.10 B166.98%
2005-06-30โ‚น3.03 B136.28%
2004-06-30โ‚น1.28 B474.78%
2003-06-30โ‚น0.22 B
2001-06-30โ‚น0.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NRC Health
NRC
โ‚น12.22 B-46.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น24.41 M-99.89% Bahamas